Medical Device Legal News with Sam Bernstein: Episode 9

McGuireWoods LLP
Contact
The US Supreme Court rules that, under the Federal False Claims Act (FCA), the knowledge and subjective beliefs of a defendant at the time a false claim was submitted are determinative, and post hoc objectively reasonable rationalizations of that behavior based on an interpretation of an ambiguous law do not excuse the violation; the FDA issues updated draft guidance for good clinical practices (GCP), incorporating the International Council for Harmonisation’s (ICH) recently updated E6(R3) draft guideline; the FDA issues a warning See more +
The US Supreme Court rules that, under the Federal False Claims Act (FCA), the knowledge and subjective beliefs of a defendant at the time a false claim was submitted are determinative, and post hoc objectively reasonable rationalizations of that behavior based on an interpretation of an ambiguous law do not excuse the violation; the FDA issues updated draft guidance for good clinical practices (GCP), incorporating the International Council for Harmonisation’s (ICH) recently updated E6(R3) draft guideline; the FDA issues a warning letter with implications for devices that shut off at the end of a subscription or report a limited number of events; the FDA requests public comments on the development of medical technologies for use in non-clinical care settings to advance health equity. See less -
Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© McGuireWoods LLP

Written by:

McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide